{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:46:59Z","timestamp":1791190019764,"version":"4.1.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,2,28]],"date-time":"2007-02-28T00:00:00Z","timestamp":1172620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,2,28]],"date-time":"2007-02-28T00:00:00Z","timestamp":1172620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1007\/s00213-007-0721-3","type":"journal-article","created":{"date-parts":[[2007,2,27]],"date-time":"2007-02-27T15:03:14Z","timestamp":1172588594000},"page":"325-336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":150,"title":["Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of \u03949-tetrahydrocannabinol"],"prefix":"10.1007","volume":"192","author":[{"given":"A. A.","family":"Boucher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. R.","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Micheau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Karl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,2,28]]},"reference":[{"key":"721_CR1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/BF02244861","volume":"114","author":"JB Acri","year":"1994","unstructured":"Acri JB, Morse DE, Popke EJ, Grunberg NE (1994) Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex in rats. Psychopharmacology (Berl) 114:369\u2013374","journal-title":"Psychopharmacology (Berl)"},{"key":"721_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.pnpbp.2005.01.010","volume":"29","author":"L Albrechet-Souza","year":"2005","unstructured":"Albrechet-Souza L, Oliveira AR, De Luca MC, Tomazini FM, Santos NR, Brandao ML (2005) A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia. Prog Neuropsychopharmacol Biol Psychiatry 29:571\u2013579","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"721_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0014-2999(98)00433-6","volume":"354","author":"JC Arnold","year":"1998","unstructured":"Arnold JC, Topple AN, Hunt GE, McGregor IS (1998) Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine. Eur J Pharmacol 354:9\u201316","journal-title":"Eur J Pharmacol"},{"key":"721_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0006-8993(01)03127-4","volume":"921","author":"JC Arnold","year":"2001","unstructured":"Arnold JC, Topple AN, Mallet PE, Hunt GE, McGregor IS (2001) The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain. Brain Res 921:240\u2013255","journal-title":"Brain Res"},{"key":"721_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1192\/bjp.184.2.110","volume":"184","author":"L Arseneault","year":"2004","unstructured":"Arseneault L, Cannon M, Witton J, Murray RM (2004) Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 184:110\u2013117","journal-title":"Br J Psychiatry"},{"key":"721_CR6","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s00213-005-0251-9","volume":"184","author":"GN Balerio","year":"2006","unstructured":"Balerio GN, Aso E, Maldonado R (2006) Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology (Berl) 184:504\u2013513","journal-title":"Psychopharmacology (Berl)"},{"key":"721_CR7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0022-3956(99)00039-4","volume":"33","author":"TA Bayer","year":"1999","unstructured":"Bayer TA, Falkai P, Maier W (1999) Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the \u201ctwo hit hypothesis\u201d. J Psychiatr Res 33:543\u2013548","journal-title":"J Psychiatr Res"},{"key":"721_CR8","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S0091-3057(02)00958-9","volume":"73","author":"LJ Bertoglio","year":"2002","unstructured":"Bertoglio LJ, Carobrez AP (2002) Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus maze. Pharmacol Biochem Behav 73:963\u2013969","journal-title":"Pharmacol Biochem Behav"},{"key":"721_CR9","first-page":"571","volume":"19","author":"JR Boissier","year":"1964","unstructured":"Boissier JR, Simon P, Lwoff JM (1964) Use of a particular mouse reaction (hole board method) for the study of psychotropic drugs. Therapie 19:571\u2013583","journal-title":"Therapie"},{"key":"721_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresrev.2004.01.001","volume":"45","author":"P Boksa","year":"2004","unstructured":"Boksa P (2004) Animal models of obstetric complications in relation to schizophrenia. Brain Res Brain Res Rev 45:1\u201317","journal-title":"Brain Res Brain Res Rev"},{"key":"721_CR11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s00213-004-1941-4","volume":"177","author":"M Bortolato","year":"2005","unstructured":"Bortolato M, Aru GN, Frau R, Orru M, Luckey GC, Boi G, Gessa GL (2005) The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague\u2013Dawley rats. Psychopharmacology (Berl) 177:264\u2013271","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"721_CR12","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1038\/sj.npp.1301061","volume":"31","author":"M Bortolato","year":"2006","unstructured":"Bortolato M, Campolongo P, Mangieri RA, Scattoni ML, Frau R, Trezza V, La Rana G, Russo R, Calignano A, Gessa GL, Cuomo V, Piomelli D (2006) Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharmacology 31(12):2652\u20132659","journal-title":"Neuropsychopharmacology"},{"key":"721_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejphar.2004.04.036","volume":"494","author":"JA Bouwknecht","year":"2004","unstructured":"Bouwknecht JA, van der Gugten J, Groenink L, Olivier B, Paylor RE (2004) Effects of repeated testing in two inbred strains on flesinoxan dose\u2013response curves in three mouse models for anxiety. Eur J Pharmacol 494:35\u201344","journal-title":"Eur J Pharmacol"},{"key":"721_CR14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jpsychires.2004.09.003","volume":"39","author":"RJ Braga","year":"2005","unstructured":"Braga RJ, Mendlowicz MV, Marrocos RP, Figueira IL (2005) Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life. J Psychiatr Res 39:409\u2013414","journal-title":"J Psychiatr Res"},{"key":"721_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.0.CO;2-U","volume":"97","author":"AG Cardno","year":"2000","unstructured":"Cardno AG, Gottesman II (2000) Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet 97:12\u201317","journal-title":"Am J Med Genet"},{"key":"721_CR16","first-page":"586","volume":"277","author":"DR Compton","year":"1996","unstructured":"Compton DR, Aceto MD, Lowe J, Martin BR (1996) In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J Pharmacol Exp Ther 277:586\u2013594","journal-title":"J Pharmacol Exp Ther"},{"key":"721_CR17","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/0091-3057(89)90033-6","volume":"32","author":"B Costall","year":"1989","unstructured":"Costall B, Jones BJ, Kelly ME, Naylor RJ, Tomkins DM (1989) Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol Biochem Behav 32:777\u2013785","journal-title":"Pharmacol Biochem Behav"},{"key":"721_CR18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10673229609017192","volume":"3","author":"JT Coyle","year":"1996","unstructured":"Coyle JT (1996) The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry 3:241\u2013253","journal-title":"Harv Rev Psychiatry"},{"key":"721_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0149-7634(85)90030-2","volume":"9","author":"JN Crawley","year":"1985","unstructured":"Crawley JN (1985) Exploratory behavior models of anxiety in mice. Neurosci Biobehav Rev 9:37\u201344","journal-title":"Neurosci Biobehav Rev"},{"key":"721_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0006-8993(98)01258-X","volume":"835","author":"JN Crawley","year":"1999","unstructured":"Crawley JN (1999) Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res 835:18\u201326","journal-title":"Brain Res"},{"key":"721_CR21","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0091-3057(02)00813-4","volume":"72","author":"SE Cruz-Morales","year":"2002","unstructured":"Cruz-Morales SE, Santos NR, Brandao ML (2002) One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat. Pharmacol Biochem Behav 72:973\u2013978","journal-title":"Pharmacol Biochem Behav"},{"key":"721_CR22","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1126\/science.154.3756.1577","volume":"154","author":"JC DeFries","year":"1966","unstructured":"DeFries JC, Hegmann JP, Weir MW (1966) Open-field behavior in mice: evidence for a major gene effect mediated by the visual system. Science 154:1577\u20131579","journal-title":"Science"},{"key":"721_CR23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11920-002-0026-5","volume":"4","author":"L Degenhardt","year":"2002","unstructured":"Degenhardt L, Hall W (2002) Cannabis and psychosis. Curr Psychiatry Rep 4:191\u2013196","journal-title":"Curr Psychiatry Rep"},{"key":"721_CR24","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1046\/j.1360-0443.2001.961116037.x","volume":"96","author":"L Degenhardt","year":"2001","unstructured":"Degenhardt L, Hall W, Lynskey M (2001) Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Addiction 96:1603\u20131614","journal-title":"Addiction"},{"key":"721_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0376-8716(03)00064-4","volume":"71","author":"L Degenhardt","year":"2003","unstructured":"Degenhardt L, Hall W, Lynskey M (2003) Testing hypotheses about the relationship between cannabis use and psychosis. Drug Alcohol Depend 71:37\u201348","journal-title":"Drug Alcohol Depend"},{"key":"721_CR26","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/j.1749-6632.1969.tb12983.x","volume":"159","author":"VH Denenberg","year":"1969","unstructured":"Denenberg VH (1969) Open-field behavior in the rat: what does it mean? Ann N Y Acad Sci 159:852\u2013859","journal-title":"Ann N Y Acad Sci"},{"key":"721_CR27","first-page":"4","volume":"55","author":"AK Dixon","year":"1994","unstructured":"Dixon AK, Huber C, Lowe DA (1994) Clozapine promotes approach-oriented behavior in male mice. J Clin Psychiatry 55:4\u20137","journal-title":"J Clin Psychiatry"},{"key":"721_CR28","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1017\/S0033291705005428","volume":"35","author":"J Duan","year":"2005","unstructured":"Duan J, Martinez M, Sanders AR, Hou C, Krasner AJ, Schwartz DB, Gejman PV (2005) Neuregulin 1 (NRG1) and schizophrenia: analysis of a US family sample and the evidence in the balance. Psychol Med 35:1599\u20131610","journal-title":"Psychol Med"},{"key":"721_CR29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S0165-0173(99)00002-8","volume":"29","author":"GE Duncan","year":"1999","unstructured":"Duncan GE, Sheitman BB, Lieberman JA (1999) An integrated view of pathophysiological models of schizophrenia. Brain Res Brain Res Rev 29:250\u2013264","journal-title":"Brain Res Brain Res Rev"},{"key":"721_CR30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00008877-200006000-00006","volume":"11","author":"BA Ellenbroek","year":"2000","unstructured":"Ellenbroek BA, Cools AR (2000) Animal models for the negative symptoms of schizophrenia. Behav Pharmacol 11:223\u2013233","journal-title":"Behav Pharmacol"},{"key":"721_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0166-4328(97)02286-9","volume":"87","author":"EF Espejo","year":"1997","unstructured":"Espejo EF (1997) Effects of weekly or daily exposure to the elevated plus-maze in male mice. Behav Brain Res 87:233\u2013238","journal-title":"Behav Brain Res"},{"key":"721_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0014-4827(02)00102-7","volume":"284","author":"DL Falls","year":"2003","unstructured":"Falls DL (2003) Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 284:14\u201330","journal-title":"Exp Cell Res"},{"key":"721_CR33","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/0006-3223(95)00046-1","volume":"38","author":"NB Farber","year":"1995","unstructured":"Farber NB, Wozniak DF, Price MT, Labruyere J, Huss J, St Peter H, Olney JW (1995) Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia? Biol Psychiatry 38:788\u2013796","journal-title":"Biol Psychiatry"},{"key":"721_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-244X-5-17","volume":"5","author":"B Favrat","year":"2005","unstructured":"Favrat B, Menetrey A, Augsburger M, Rothuizen LE, Appenzeller M, Buclin T, Pin M, Mangin P, Giroud C (2005) Two cases of \u201ccannabis acute psychosis\u201d following the administration of oral cannabis. BMC Psychiatry 5:17","journal-title":"BMC Psychiatry"},{"key":"721_CR35","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00213-004-1851-5","volume":"175","author":"E Fernandez-Espejo","year":"2004","unstructured":"Fernandez-Espejo E, Galan-Rodriguez B (2004) Sensorimotor gating in mice is disrupted after AM404, an anandamide reuptake and degradation inhibitor. Psychopharmacology (Berl) 175:220\u2013224","journal-title":"Psychopharmacology (Berl)"},{"key":"721_CR36","first-page":"151","volume-title":"Animal models of psychiatric disorders. Selected models of anxiety, depression and psychosis","author":"SE File","year":"1988","unstructured":"File SE (1988) How good is social interaction as a test of anxiety? In: Simon P, Soubri\u00e9 P, Wildlocher D (eds) Animal models of psychiatric disorders. Selected models of anxiety, depression and psychosis. Karger, Basel, M\u00fcnchen, Paris, London, New York, New Delhi, Singapore, Tokyo, and Sydney, pp 151\u2013166"},{"key":"721_CR37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/BF02244419","volume":"100","author":"SE File","year":"1990","unstructured":"File SE (1990) One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology (Berl) 100:281\u2013282","journal-title":"Psychopharmacology (Berl)"},{"key":"721_CR38","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/BF02245751","volume":"102","author":"SE File","year":"1990","unstructured":"File SE, Mabbutt PS, Hitchcott PK (1990) Characterisation of the phenomenon of \u201cone-trial tolerance\u201d to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology (Berl) 102:98\u2013101","journal-title":"Psychopharmacology (Berl)"},{"key":"721_CR39","doi-asserted-by":"crossref","unstructured":"Geyer MA, Swerdlow NR (1998) Measurement of startle response, prepulse inhibition, and habituation. In: Crawley JN, Skolnick P (eds) Current protocols in neuroscience, New York, pp 8.7.1\u20138.7.15","DOI":"10.1002\/0471142301.ns0807s03"},{"key":"721_CR40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s002130100811","volume":"156","author":"MA Geyer","year":"2001","unstructured":"Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 156:117\u2013154","journal-title":"Psychopharmacology (Berl)"},{"key":"721_CR41","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1469-8986.1975.tb01284.x","volume":"12","author":"FK Graham","year":"1975","unstructured":"Graham FK (1975) Presidential Address, 1974. The more or less startling effects of weak prestimulation. Psychophysiology 12:238\u2013248","journal-title":"Psychophysiology"},{"key":"721_CR42","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.eurpsy.2004.09.013","volume":"20","author":"A Grech","year":"2005","unstructured":"Grech A, Van Os J, Jones PB, Lewis SW, Murray RM (2005) Cannabis use and outcome of recent onset psychosis. Eur Psychiatr 20:349\u2013353","journal-title":"Eur Psychiatr"},{"key":"721_CR43","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/09595239800187271","volume":"17","author":"W Hall","year":"1998","unstructured":"Hall W (1998) Cannabis use and psychosis. Drug Alcohol Rev 17:433\u2013444","journal-title":"Drug Alcohol Rev"},{"key":"721_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1046\/j.1440-1614.2000.00685.x","volume":"34","author":"W Hall","year":"2000","unstructured":"Hall W, Degenhardt L (2000) Cannabis use and psychosis: a review of clinical and epidemiological evidence. Aust N Z J Psychiatry 34:26\u201334","journal-title":"Aust N Z J Psychiatry"},{"key":"721_CR45","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/sj.mp.4001434","volume":"9","author":"R Hashimoto","year":"2004","unstructured":"Hashimoto R, Straub RE, Weickert CS, Hyde TM, Kleinman JE, Weinberger DR (2004) Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry 9:299\u2013307","journal-title":"Mol Psychiatry"},{"key":"721_CR46","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/schbul\/sbi027","volume":"31","author":"C Henquet","year":"2005","unstructured":"Henquet C, Murray R, Linszen D, van Os J (2005) The environment and schizophrenia: the role of cannabis use. Schizophr Bull 31:608\u2013612","journal-title":"Schizophr Bull"},{"key":"721_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1192\/bjp.bp.105.014308","volume":"189","author":"L Hides","year":"2006","unstructured":"Hides L, Dawe S, Kavanagh DJ, Young RM (2006) Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study. Br J Psychiatry 189:137\u2013143","journal-title":"Br J Psychiatry"},{"key":"721_CR48","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1121\/1.1910776","volume":"43","author":"HS Hoffman","year":"1968","unstructured":"Hoffman HS, Searle JL (1968) Acoustic and temporal factors in the evocation of startle. J Acoust Soc Am 43:269\u2013282","journal-title":"J Acoust Soc Am"},{"key":"721_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0091-3057(95)02126-4","volume":"54","author":"S Hogg","year":"1996","unstructured":"Hogg S (1996) A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54:21\u201330","journal-title":"Pharmacol Biochem Behav"},{"key":"721_CR50","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0149-7634(99)00030-5","volume":"23","author":"A Holmes","year":"1999","unstructured":"Holmes A, Rodgers RJ (1999) Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosci Biobehav Rev 23:971\u2013980","journal-title":"Neurosci Biobehav Rev"},{"key":"721_CR51","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/sj.mp.4001456","volume":"9","author":"N Iwata","year":"2004","unstructured":"Iwata N, Suzuki T, Ikeda M, Kitajima T, Yamanouchi Y, Inada T, Ozaki N (2004) No association with the neuregulin 1 haplotype to Japanese schizophrenia. Mol Psychiatry 9:126\u2013127","journal-title":"Mol Psychiatry"},{"key":"721_CR52","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1192\/bjp.178.2.116","volume":"178","author":"A Johns","year":"2001","unstructured":"Johns A (2001) Psychiatric effects of cannabis. Br J Psychiatry 178:116\u2013122","journal-title":"Br J Psychiatry"},{"key":"721_CR53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1078\/0940-2993-00301","volume":"55","author":"T Karl","year":"2003","unstructured":"Karl T, Pabst R, von Horsten S (2003) Behavioral phenotyping of mice in pharmacological and toxicological research. Exp Toxicol Pathol 55:69\u201383","journal-title":"Exp Toxicol Pathol"},{"key":"721_CR54","doi-asserted-by":"crossref","unstructured":"Karl T, Duffy L, Scimone A, Harvey RP, Schofield P (2006) Altered motor activity, exploration, and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia. Genes Brain Behav (in press)","DOI":"10.1111\/j.1601-183X.2006.00298.x"},{"key":"721_CR55","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0031-9384(01)00587-X","volume":"74","author":"A Kask","year":"2001","unstructured":"Kask A, Nguyen HP, Pabst R, von Horsten S (2001) Factors influencing behavior of group-housed male rats in the social interaction test: focus on cohort removal. Physiol Behav 74:277\u2013282","journal-title":"Physiol Behav"},{"key":"721_CR56","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/hup.286","volume":"16","author":"V Kumari","year":"2001","unstructured":"Kumari V, Soni W, Sharma T (2001) Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia. Hum Psychopharmacol 16:321\u2013326","journal-title":"Hum Psychopharmacol"},{"key":"721_CR57","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.1073\/pnas.0602002103","volume":"103","author":"AJ Law","year":"2006","unstructured":"Law AJ, Lipska BK, Weickert CS, Hyde TM, Straub RE, Hashimoto R, Harrison PJ, Kleinman JE, Weinberger DR (2006) Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5\u2032 SNPs associated with the disease. Proc Natl Acad Sci USA 103:6747\u20136752","journal-title":"Proc Natl Acad Sci USA"},{"key":"721_CR58","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/BF02247133","volume":"102","author":"C Lee","year":"1990","unstructured":"Lee C, Rodgers RJ (1990) Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations. Psychopharmacology (Berl) 102:507\u2013513","journal-title":"Psychopharmacology (Berl)"},{"key":"721_CR59","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.bbr.2004.03.012","volume":"154","author":"A Leng","year":"2004","unstructured":"Leng A, Yee BK, Feldon J, Ferger B (2004) Acoustic startle response, prepulse inhibition, and spontaneous locomotor activity in MPTP-treated mice. Behav Brain Res 154:449\u2013456","journal-title":"Behav Brain Res"},{"key":"721_CR60","doi-asserted-by":"publisher","first-page":"895","DOI":"10.2165\/00023210-200418130-00005","volume":"18","author":"FM Leweke","year":"2004","unstructured":"Leweke FM, Gerth CW, Klosterkotter J (2004) Cannabis-associated psychosis: current status of research. CNS Drugs 18:895\u2013910","journal-title":"CNS Drugs"},{"key":"721_CR61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archpsyc.1994.03950040017002","volume":"51","author":"DH Linszen","year":"1994","unstructured":"Linszen DH, Dingemans PM, Lenior ME (1994) Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 51:273\u2013279","journal-title":"Arch Gen Psychiatry"},{"key":"721_CR62","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bbr.2005.07.009","volume":"166","author":"DT Malone","year":"2006","unstructured":"Malone DT, Taylor DA (2006) The effect of delta9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats. Behav Brain Res 166:101\u2013109","journal-title":"Behav Brain Res"},{"key":"721_CR63","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0893-133X(89)90035-3","volume":"2","author":"RS Mansbach","year":"1989","unstructured":"Mansbach RS, Geyer MA (1989) Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology 2:299\u2013308","journal-title":"Neuropsychopharmacology"},{"key":"721_CR64","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/BF00212846","volume":"94","author":"RS Mansbach","year":"1988","unstructured":"Mansbach RS, Geyer MA, Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology (Berl) 94:507\u2013514","journal-title":"Psychopharmacology (Berl)"},{"key":"721_CR65","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/BF02247436","volume":"124","author":"RS Mansbach","year":"1996","unstructured":"Mansbach RS, Rovetti CC, Winston EN, Lowe JA 3rd (1996) Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats. Psychopharmacology (Berl) 124:315\u2013322","journal-title":"Psychopharmacology (Berl)"},{"key":"721_CR66","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00213-002-1240-x","volume":"165","author":"RS Martin","year":"2003","unstructured":"Martin RS, Secchi RL, Sung E, Lemaire M, Bonhaus DW, Hedley LR, Lowe DA (2003) Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat. Psychopharmacology (Berl) 165:128\u2013135","journal-title":"Psychopharmacology (Berl)"},{"key":"721_CR67","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1037\/h0043788","volume":"48","author":"KC Montgomery","year":"1958","unstructured":"Montgomery KC (1958) The relation between fear induced by novel stimulation and exploratory behavior. J Comp Physiol Psychol 48:254\u2013260","journal-title":"J Comp Physiol Psychol"},{"key":"721_CR68","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.pbb.2006.05.018","volume":"84","author":"H Nagai","year":"2006","unstructured":"Nagai H, Egashira N, Sano K, Ogata A, Mizuki A, Mishima K, Iwasaki K, Shoyama Y, Nishimura R, Fujiwara M (2006) Antipsychotics improve delta9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice. Pharmacol Biochem Behav 84:330\u2013336","journal-title":"Pharmacol Biochem Behav"},{"key":"721_CR69","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1023\/A:1025718531997","volume":"33","author":"JM Nyberg","year":"2003","unstructured":"Nyberg JM, Vekovischeva O, Sandnabba NK (2003) Anxiety profiles of mice selectively bred for intermale aggression. Behav Genet 33:503\u2013511","journal-title":"Behav Genet"},{"key":"721_CR70","first-page":"1002","volume":"253","author":"ES Onaivi","year":"1990","unstructured":"Onaivi ES, Green MR, Martin BR (1990) Pharmacological characterization of cannabinoids in the elevated plus maze. J Pharmacol Exp Ther 253:1002\u20131009","journal-title":"J Pharmacol Exp Ther"},{"key":"721_CR71","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0166-4328(96)00139-8","volume":"72","author":"ES Onaivi","year":"1995","unstructured":"Onaivi ES, Chakrabarti A, Gwebu ET, Chaudhuri G (1995) Neurobehavioral effects of delta 9-THC and cannabinoid (CB1) receptor gene expression in mice. Behav Brain Res 72:115\u2013125","journal-title":"Behav Brain Res"},{"key":"721_CR72","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/01.wnr.0000192738.31029.0a","volume":"17","author":"CM O\u2019Tuathaigh","year":"2006","unstructured":"O\u2019Tuathaigh CM, O\u2019Sullivan GJ, Kinsella A, Harvey RP, Tighe O, Croke DT, Waddington JL (2006) Sexually dimorphic changes in the exploratory and habituation profiles of heterozygous neuregulin-1 knockout mice. Neuroreport 17:79\u201383","journal-title":"Neuroreport"},{"key":"721_CR73","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","volume":"14","author":"S Pellow","year":"1985","unstructured":"Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149\u2013167","journal-title":"J Neurosci Methods"},{"key":"721_CR74","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00213-006-0307-5","volume":"184","author":"P Postma","year":"2006","unstructured":"Postma P, Gray JA, Sharma T, Geyer M, Mehrotra R, Das M, Zachariah E, Hines M, Williams SC, Kumari V (2006) A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia. Psychopharmacology (Berl) 184:589\u2013599","journal-title":"Psychopharmacology (Berl)"},{"key":"721_CR75","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/00008877-199711000-00003","volume":"8","author":"RJ Rodgers","year":"1997","unstructured":"Rodgers RJ (1997) Animal models of \u2018anxiety\u2019: where next? Behav Pharmacol 8:477\u2013496; discussion 497\u2013504","journal-title":"Behav Pharmacol"},{"key":"721_CR76","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0091-3057(95)00138-M","volume":"52","author":"RJ Rodgers","year":"1995","unstructured":"Rodgers RJ, Johnson NJ (1995) Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 52:297\u2013303","journal-title":"Pharmacol Biochem Behav"},{"key":"721_CR77","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/BF02245704","volume":"113","author":"RJ Rodgers","year":"1993","unstructured":"Rodgers RJ, Shepherd JK (1993) Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light\/dark tests of anxiety in mice. Psychopharmacology (Berl) 113:237\u2013242","journal-title":"Psychopharmacology (Berl)"},{"key":"721_CR78","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/BF02253596","volume":"106","author":"RJ Rodgers","year":"1992","unstructured":"Rodgers RJ, Lee C, Shepherd JK (1992) Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology (Berl) 106:102\u2013110","journal-title":"Psychopharmacology (Berl)"},{"key":"721_CR79","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0091-3057(95)02156-6","volume":"54","author":"RJ Rodgers","year":"1996","unstructured":"Rodgers RJ, Johnson NJ, Cole JC, Dewar CV, Kidd GR, Kimpson PH (1996) Plus-maze retest profile in mice: importance of initial stages of trail 1 and response to post-trail cholinergic receptor blockade. Pharmacol Biochem Behav 54:41\u201350","journal-title":"Pharmacol Biochem Behav"},{"key":"721_CR80","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/00008877-200509000-00013","volume":"16","author":"RJ Rodgers","year":"2005","unstructured":"Rodgers RJ, Evans PM, Murphy A (2005) Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naive and plus-maze-experienced mice. Behav Pharmacol 16:405\u2013413","journal-title":"Behav Pharmacol"},{"key":"721_CR81","first-page":"200","volume":"58","author":"M Rutkowska","year":"2006","unstructured":"Rutkowska M, Jamontt J, Gliniak H (2006) Effects of cannabinoids on the anxiety-like response in mice. Pharmacol Rep 58:200\u2013206","journal-title":"Pharmacol Rep"},{"key":"721_CR82","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00008877-200202000-00003","volume":"13","author":"M Schneider","year":"2002","unstructured":"Schneider M, Koch M (2002) The cannabinoid agonist WIN 55,212-2 reduces sensorimotor gating and recognition memory in rats. Behav Pharmacol 13:29\u201337","journal-title":"Behav Pharmacol"},{"key":"721_CR83","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/00005053-198711000-00001","volume":"175","author":"FR Schneier","year":"1987","unstructured":"Schneier FR, Siris SG (1987) A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice. J Nerv Ment Dis 175:641\u2013652","journal-title":"J Nerv Ment Dis"},{"key":"721_CR84","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/j.1440-1614.2006.01840.x","volume":"40","author":"D Schofield","year":"2006","unstructured":"Schofield D, Tennant C, Nash L, Degenhardt L, Cornish A, Hobbs C, Brennan G (2006) Reasons for cannabis use in psychosis. Aust N Z J Psychiatry 40:570\u2013574","journal-title":"Aust N Z J Psychiatry"},{"key":"721_CR85","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.brainres.2005.01.030","volume":"1038","author":"P Snodgrass-Belt","year":"2005","unstructured":"Snodgrass-Belt P, Gilbert JL, Davis FC (2005) Central administration of transforming growth factor-alpha and neuregulin-1 suppress active behaviors and cause weight loss in hamsters. Brain Res 1038:171\u2013182","journal-title":"Brain Res"},{"key":"721_CR86","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00008877-200202000-00002","volume":"13","author":"CC Stanley-Cary","year":"2002","unstructured":"Stanley-Cary CC, Harris C, Martin-Iverson MT (2002) Differing effects of the cannabinoid agonist, CP 55,940, in an alcohol or Tween 80 solvent, on prepulse inhibition of the acoustic startle reflex in the rat. Behav Pharmacol 13:15\u201328","journal-title":"Behav Pharmacol"},{"key":"721_CR87","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1086\/342734","volume":"71","author":"H Stefansson","year":"2002","unstructured":"Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, Hjaltason O, Birgisdottir B, Jonsson H, Gudnadottir VG, Gudmundsdottir E, Bjornsson A, Ingvarsson B, Ingason A, Sigfusson S, Hardardottir H, Harvey RP, Lai D, Zhou M, Brunner D, Mutel V, Gonzalo A, Lemke G, Sainz J, Johannesson G, Andresson T, Gudbjartsson D, Manolescu A, Frigge ML, Gurney ME, Kong A, Gulcher JR, Petursson H, Stefansson K (2002) Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71:877\u2013892","journal-title":"Am J Hum Genet"},{"key":"721_CR88","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/archpsyc.60.12.1187","volume":"60","author":"PF Sullivan","year":"2003","unstructured":"Sullivan PF, Kendler KS, Neale MC (2003) Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60:1187\u20131192","journal-title":"Arch Gen Psychiatry"},{"key":"721_CR89","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/archpsyc.1992.01820120071010","volume":"49","author":"ES Susser","year":"1992","unstructured":"Susser ES, Lin SP (1992) Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944\u20131945. Arch Gen Psychiatry 49:983\u2013988","journal-title":"Arch Gen Psychiatry"},{"key":"721_CR90","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/sj.mp.4001436","volume":"9","author":"JX Tang","year":"2004","unstructured":"Tang JX, Chen WY, He G, Zhou J, Gu NF, Feng GY, He L (2004) Polymorphisms within 5\u2032 end of the neuregulin 1 gene are genetically associated with schizophrenia in the Chinese population. Mol Psychiatry 9:11\u201312","journal-title":"Mol Psychiatry"},{"key":"721_CR91","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/da.10083","volume":"17","author":"P Tibbo","year":"2003","unstructured":"Tibbo P, Swainson J, Chue P, LeMelledo JM (2003) Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophrenia. Depress Anxiety 17:65\u201372","journal-title":"Depress Anxiety"},{"key":"721_CR92","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.comppsych.2004.11.005","volume":"46","author":"MH Townsend","year":"2005","unstructured":"Townsend MH, Wilson MS (2005) Comorbid anxiety disorders and divalproex sodium use among partial hospital patients with psychotic disorders. Compr Psychiatry 46:368\u2013370","journal-title":"Compr Psychiatry"},{"key":"721_CR93","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1440-1614.2005.01626.x","volume":"39","author":"M van den Buuse","year":"2005","unstructured":"van den Buuse M, Garner B, Gogos A, Kusljic S (2005) Importance of animal models in schizophrenia research. Aust N Z J Psychiatry 39:550\u2013557","journal-title":"Aust N Z J Psychiatry"},{"key":"721_CR94","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0166-4328(00)00240-0","volume":"115","author":"MM van Gaalen","year":"2000","unstructured":"van Gaalen MM, Steckler T (2000) Behavioural analysis of four mouse strains in an anxiety test battery. Behav Brain Res 115:95\u2013106","journal-title":"Behav Brain Res"},{"key":"721_CR95","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/aje\/kwf043","volume":"156","author":"J van Os","year":"2002","unstructured":"van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H (2002) Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 156:319\u2013327","journal-title":"Am J Epidemiol"},{"key":"721_CR96","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s00213-006-0356-9","volume":"186","author":"SA Varvel","year":"2006","unstructured":"Varvel SA, Wiley JL, Yang R, Bridgen DT, Long K, Lichtman AH, Martin BR (2006) Interactions between THC and cannabidiol in mouse models of cannabinoid activity. Psychopharmacology (Berl) 186:226\u2013234","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"721_CR97","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.biopsych.2006.03.017","volume":"60","author":"C Walss-Bass","year":"2006","unstructured":"Walss-Bass C, Liu W, Lew DF, Villegas R, Montero P, Dassori A, Leach RJ, Almasy L, Escamilla M, Raventos H (2006) A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia. Biol Psychiatry 60(6):548\u2013553","journal-title":"Biol Psychiatry"},{"key":"721_CR98","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0166-4328(03)00036-6","volume":"143","author":"JH Wang","year":"2003","unstructured":"Wang JH, Short J, Ledent C, Lawrence AJ, van den Buuse M (2003) Reduced startle habituation and prepulse inhibition in mice lacking the adenosine A2A receptor. Behav Brain Res 143:201\u2013207","journal-title":"Behav Brain Res"},{"key":"721_CR99","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0149-7634(03)00035-6","volume":"27","author":"AH Wong","year":"2003","unstructured":"Wong AH, Van Tol HH (2003) Schizophrenia: from phenomenology to neurobiology. Neurosci Biobehav Rev 27:269\u2013306","journal-title":"Neurosci Biobehav Rev"},{"key":"721_CR100","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/0031-9384(91)90572-6","volume":"50","author":"IK Wright","year":"1991","unstructured":"Wright IK, Upton N, Marsden CA (1991) Resocialisation of isolation-reared rats does not alter their anxiogenic profile on the elevated X-maze model of anxiety. Physiol Behav 50:1129\u20131132","journal-title":"Physiol Behav"},{"key":"721_CR101","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/sj.mp.4001377","volume":"8","author":"JZ Yang","year":"2003","unstructured":"Yang JZ, Si TM, Ruan Y, Ling YS, Han YH, Wang XL, Zhou M, Zhang HY, Kong QM, Liu C, Zhang DR, Yu YQ, Liu SZ, Ju GZ, Shu L, Ma DL, Zhang D (2003) Association study of neuregulin 1 gene with schizophrenia. Mol Psychiatry 8:706\u2013709","journal-title":"Mol Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-007-0721-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-007-0721-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-007-0721-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-007-0721-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T01:13:25Z","timestamp":1652836405000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-007-0721-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,28]]},"references-count":101,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["721"],"URL":"https:\/\/doi.org\/10.1007\/s00213-007-0721-3","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,28]]},"assertion":[{"value":"13 July 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}